2010
DOI: 10.1177/0897190009360022
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Sclerosis

Abstract: Multiple sclerosis, an autoimmune disorder causing the destruction of the impulse carrying myelin sheath of neurons, can be a debilitating and disabling disease. Symptomatic treatment has provided patients with relief through the use of antispasmodics, anticholinergics, and antidepressants, just to name a few, as well as disease treatment by decreasing progression of the illness by treating acute episodes through the use of corticosteroids, interferons, plasmapheresis, and other immunomodulators like glatirame… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Although an innovative medication to treat MS patients was unknown, a number of therapies – such as anti-inflammatory medications, interferon-beta, fingolimod, and alternative medicines – have been used to treat symptoms of MS (Mahdavian et al, 2010; Axisa and Hafler, 2016). Unfortunately, the therapies have either limited efficacy or adverse effects (Neilley et al, 1996; Gasperini and Ruggieri, 2009; Minagar, 2013; Finkelsztejn, 2014).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Although an innovative medication to treat MS patients was unknown, a number of therapies – such as anti-inflammatory medications, interferon-beta, fingolimod, and alternative medicines – have been used to treat symptoms of MS (Mahdavian et al, 2010; Axisa and Hafler, 2016). Unfortunately, the therapies have either limited efficacy or adverse effects (Neilley et al, 1996; Gasperini and Ruggieri, 2009; Minagar, 2013; Finkelsztejn, 2014).…”
Section: Resultsmentioning
confidence: 99%
“…MS patients still get drugs to combat relapses and to slow the disease: anti-inflammatory medications (corticosteroids), interferon and interferon-beta, mitoxantrone, natalizumab, an alternative treatment method, such as acupuncture, bee sting, etc. (Mahdavian et al, 2010; Axisa and Hafler, 2016). However, they have limited benefits and disabling adverse effects, such as influenza-like syndrome and self-limited feeling, associated with long-term therapy (Neilley et al, 1996; Gasperini and Ruggieri, 2009; Minagar, 2013; Finkelsztejn, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Multiple sclerosis (MS), anautoimmune-mediated degenerative disorder of the central nervous system (CNS) that affects young adults, is characterized by various neurologic dysfunctions due to progressive demyelination, oligodendrocyte death, and diffuse neurodegeneration [ [1] , [2] , [3] ]. Although the etiology of MS remains elusive, the pathogenesis of MS engages aberrant overactivation of immune responses according to results of immunological, genetic, and histopathology studies on patients with MS [ [4] , [5] , [6] , [7] ]. Although a better understanding of MS has accumulated our knowledge of the etiology and mechanism of the disease, exploration for its therapeutics is still challenging [ [4] , [5] , [6] , [7] ].…”
Section: Introductionmentioning
confidence: 99%
“…Although the etiology of MS remains elusive, the pathogenesis of MS engages aberrant overactivation of immune responses according to results of immunological, genetic, and histopathology studies on patients with MS [ [4] , [5] , [6] , [7] ]. Although a better understanding of MS has accumulated our knowledge of the etiology and mechanism of the disease, exploration for its therapeutics is still challenging [ [4] , [5] , [6] , [7] ].…”
Section: Introductionmentioning
confidence: 99%